跳至主要内容
临床试验/CTRI/2023/01/049077
CTRI/2023/01/049077尚未招募未知

To Evaluate the Efficacy of Multi-Strain Probiotics (Lactogut) in Patients with Irritable Bowel Syndrome: Double Blind Randomized Control Trial

Velbiom Probiotics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosed case of IBS using Rome III criteria
  • 2. Absence of red flag signs: anemia, fever, weight loss, per rectal bleeding, nocturnal frequency, family history of IBD, cancer
  • 3. Age 18-70 years 4. No synthetic probiotics used in prior 3 months
  • 5. No antibiotics used in previous 2 months of enrolment

排除标准

  • 1. Previous treatment with probiotics within last 3 months
  • 2. Pregnant or lactating women
  • 3. History of any previous surgical resection of the stomach, small intestine, or large intestine
  • 4. Complications from infectious enteritis, hyperthyroidism, or hypothyroidism.
  • 5. History of any diet-based intolerance (gluten or lactose intolerance).
  • 6. History of or complications from malignant tumors.
  • 7. Uncontrolled Type II diabetes mellitus.
  • 8. Allergic or sensitive to probiotic products.

研究者

发起方
Velbiom Probiotics Private Limited

相似试验